T

TPG GP A, LLC Portfolio Analytics

Investment Analysis & Holdings Breakdown

Comprehensive portfolio analytics for TPG GP A, LLC with $1.8B in long positions as of Q3 2025, 56% allocated to Healthcare, and 100% concentrated in top 10 positions.

Portfolio Value
$1.8B
Top 10 Concentration
100%
Top Sector
Healthcare (56%)
US Exposure
100%
Market Cap Focus
Mid Cap
Countries
1

Composition Analysis

Portfolio breakdown by sector, industry, and market capitalization

Sector Allocation

Healthcare: 56.20%HealthcareConsumer Cyclical: 26.80%Consumer CyclicalReal Estate: 1.10%
Healthcare
56.20%
Consumer Cyclical
26.80%
Real Estate
1.10%

Industry Breakdown

5 industries across all sectors

Medical - Care Facilities: 48.14%Medical - Care FacilitiesLeisure: 26.80%LeisureDrug Manufacturers - Specialty & Generic: 6.72%Biotechnology: 1.35%REIT - Mortgage: 1.12%
Medical - Care Facilities
Healthcare
48.14%
Leisure
Consumer Cyclical
26.80%
Drug Manufacturers - Specialty & Generic
Healthcare
6.72%
Biotechnology
Healthcare
1.35%
REIT - Mortgage
Real Estate
1.12%

Filter by Sector

Select a sector to filter industries

Market Cap Distribution

Mid Cap ($2B - $10B): 81.66%Mid Cap ($2B - $10B)Small Cap ($300M - $2B): 16.99%Small Cap ($300M - $2B)Micro Cap ($50M - $300M): 1.26%Nano Cap (< $50M): 0.08%
Mid Cap ($2B - $10B)
81.66%
Small Cap ($300M - $2B)
16.99%
Micro Cap ($50M - $300M)
1.26%
Nano Cap (< $50M)
0.08%

Portfolio Concentration

Top 10 Holdings %
100.0%
Top 20 Holdings %
100.0%
Top 50 Holdings %
100.0%
Top 100 Holdings %
100.0%

Geographic Exposure

Portfolio breakdown by country of incorporation

Domestic (US)
100.0%
International
-
Countries
1
United States of America
100.00% ($1.8B)
9 holdings

Holding Behavior

Investment patterns and position management analysis

Portfolio Stability & Commitment

Avg. Top 10
11 quarters
Avg. Top 20
11 quarters
Avg. All Positions
11 quarters
Median Holding Period
15 quarters
Persistence Rate
77.78%
Persistent Holdings Weight
86.71%
Persistent Positions
7
Longest Held
Allogene Therapeutics, Inc. Common Stock logo
Allogene Therapeutics, Inc. Common StockALLO - 15 quarters

Position Sizing & Influence

Current Quarter

Avg. New Position
0.000%
Avg. Position Weight
11.11%
Largest Position
LifeStance Health Group, Inc. Common Stock logo
LifeStance Health Group, Inc. Common StockLFST - 48.14%
Largest Ownership Stake
LifeStance Health Group, Inc. Common Stock logo
LifeStance Health Group, Inc. Common StockLFST - 41.32%
Avg. Ownership Stake
24.54%
Ownership Stake >5%
7
Ownership Stake >1%
9

Historical (Since Q4 2021)

Avg. New Position
2.80%
Avg. Ownership Stake
16.07%
Largest Position
LifeStance Health Group, Inc. Common Stock logo
LifeStance Health Group, Inc. Common StockLFST - 48.14% (Q3 2025)
Largest Ownership Stake
LifeStance Health Group, Inc. Common Stock logo
LifeStance Health Group, Inc. Common StockLFST - 46.85% (Q4 2021)

Portfolio Turnover

Current Quarter

Turnover Ratio
3.8%
Value Traded
$69.41M
Positions Added
0
Positions Exited
0

Historical (Since Q4 2021)

Avg. Turnover Ratio
17.9%
Avg. Positions Added
5
Avg. Positions Exited
5
Highest Turnover
76.4%
Q2 2025
Lowest Turnover
3.8%
Q3 2025

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.